PMCPA Case Library

Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.

1,930
Cases
291
Companies
154
Clauses
6
Code Versions

or browse all 154 ABPI clause guides ↗

Case Library Membership

Filter by Company & ABPI Clause

Search free — but unlock advanced filters to find every case involving a specific company or clause.

Filter 1,930+ cases by any of 291 companies
Filter by any of 154 ABPI Code clauses
Filter by Code version (2016, 2019, 2021…)
Full-text keyword search across all cases
Cancel any time

Already a member? Sign in →

Case Library Membership

Best value
£249 /year Save £99

inc. VAT

£29 /month

inc. VAT · cancel any time

Unlock Full Access →

Secure payment via Stripe


Need access for your team?

Company licences available for compliance teams, medical affairs, and training programmes.

Get a team quote →

1,930 cases found

12
Feb 2026

Why HCP testimonial videos trigger PMCPA breaches

I review 100’s of clinician videos and often i think: technically great, strategically risky. In CASE/0360/11/24 (Complainant v AstraZeneca) a Trixeo video…

12
Feb 2026

PMCPA Social Media Guidance 2026 Playbook for LinkedIn

I read the PMCPA Social Media Guidance 2026 with a notebook and a headache. As an ABPI Final Signatory and industry mentor…

01
Feb 2026
2015 Code Vifor Pharma UK Clause 4 Clause 28

Vifor corporate website: non-black black triangle symbol and no separation of public vs HCP content

Vifor’s corporate website displayed inverted triangle symbols in blue/grey/white (not black) on IV iron product pages and mixed public and HCP information…

01
Feb 2026
2019 Code AstraZeneca

AstraZeneca voluntary admission: employee re-tweeted product-related tweets about Forxiga and Lynparza from a personal Twitter account

AstraZeneca admitted an employee re-tweeted positive clinical-trial-related posts about Forxiga and a Lynparza news tweet from a personal account. The Panel found…

01
Feb 2026
2019 Code Bristol-Myers Squibb Pharmaceuticals Clause 7.2

Bristol-Myers Squibb voluntary admission: incorrect overall survival data in promotional article (Urology News)

Bristol-Myers Squibb admitted a promotional article misquoted 30‑month overall survival figures for intermediate/poor-risk aRCC by using ITT data. The online article was…

01
Feb 2026
2019 Code UCB Clause 3.1

UCB employee LinkedIn profile promoted unlicensed bimekizumab (AUTH/3287/12/19)

A UCB employee’s personal LinkedIn profile described work on Phase 3 axial spondyloarthropathy for bimekizumab. The Panel ruled this promoted an unlicensed…

01
Feb 2026
2019 Code Boehringer Ingelheim Clause 6

Boehringer Ingelheim voluntary admission: MIMS issue carried Spiolto Respimat advertising on more than two pages

Boehringer Ingelheim admitted that June 2019 MIMS carried a Spiolto Respimat full-page ad plus a double-sided bookmark insert, exceeding the two-page limit…

01
Feb 2026
2019 Code Otsuka Clause 9 Clause 26 Clause 28

Otsuka Europe: UK website product pages ruled to promote prescription-only medicines to the public

An anonymous employee complained that Otsuka UK webpages listed POM brand/generic names and indications. The Panel ruled the pages promoted POMs to…

01
Feb 2026
2019 Code Napp Pharmaceuticals Clause 2 Clause 9.1 Clause 18.1 Clause 19.1

AUTH/3200/5/19: Director/Media v Napp – arrangements for a New York meeting (2002)

Following BBC criticism, the PMCPA assessed a Napp-sponsored New York meeting for UK pain specialists. The Panel found breaches relating to overseas…

01
Feb 2026
2019 Code Bristol-Myers Squibb Pharmaceuticals Pfizer

GP v Pfizer and Bristol-Myers Squibb: Eliquis leavepiece renal dosing table found misleading

A GP challenged an Eliquis leavepiece claiming no dose adjustment in mild/moderate renal impairment. The PMCPA found the page misleading versus the…

1126127128129

Ask questions about any PMCPA case

Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free